Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma

被引:0
|
作者
D Wangsa
M Ryott
E Åvall-Lundqvist
F Petersson
G Elmberger
J Luo
T Ried
G Auer
E Munck-Wikland
机构
[1] Karolinska Institute,Department of Oncology
[2] Karolinska University Hospital,Pathology
[3] Genetics Branch,Department of Oto
[4] Center for Cancer Research,Rhino
[5] National Cancer Institute,Laryngology
[6] National Institutes of Health,Department of Gynaecologic Oncology
[7] Head and Neck Surgery,Department of Medical Epidemiology and Biostatistics
[8] Karolinska University Hospital,undefined
[9] Radiumhemmet,undefined
[10] Karolinska University Hospital,undefined
[11] Karolinska Institutet,undefined
来源
British Journal of Cancer | 2008年 / 99卷
关键词
oral cancer; Ki-67; locoregional recurrence; ploidy; genomic instability;
D O I
暂无
中图分类号
学科分类号
摘要
Oral tongue squamous cell carcinoma (OTSCC) is an aggressive cancer associated with poor prognosis. Methods for determining the aggressiveness of OTSCC from analysis of the primary tumour specimen are thus highly desirable. We investigated whether genomic instability and proliferative activity (by means of Ki-67 activity) could be of clinical use for prediction of locoregional recurrence in 76 pretreatment OTSCC paraffin samples (stage I, n=22; stage II, n=33; stage III, n=8; stage IV, n=13). Eleven surgical tumour specimens were also analysed for remnants of proliferative activity after preoperative radiotherapy. Ninety-seven percent of cases (n=72) were characterised as being aneuploid as measured by means of image cytometry. Preoperative radiotherapy (50–68 Gy) resulted in significant reduction of proliferative activity in all patients for which post-treatment biopsies were available (P-value=0.001). Proliferative activity was not associated with response to radiation in stage II patients. However, we report a significant correlation between high proliferation rates and locoregional recurrences in stage I OTSCC patients (P-value=0.028). High-proliferative activity is thus related to an elevated risk of recurrence after surgery alone. We therefore conclude that Ki-67 expression level is a potentially useful clinical marker for predicting recurrence in surgically treated stage I OTSCC.
引用
收藏
页码:1121 / 1128
页数:7
相关论文
共 50 条
  • [21] Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients
    Brockton, Nigel T.
    Lohavanichbutr, Pawadee
    Enwere, Emeka K.
    Upton, Melissa P.
    Kornaga, Elizabeth N.
    Nakoneshny, Steven C.
    Bose, Pinaki
    Chen, Chu
    Dort, Joseph C.
    ONCOLOGY LETTERS, 2017, 14 (05) : 5434 - 5442
  • [22] Recurrence and survival in early breast cancer in relation to Ki-67 expression
    Gerson-Cwilich, Raquel
    Alban-de la Torre, Luis Fernando
    Villalobos-Prieto, Alberto
    Lezid Padilla-Rodriguez, Alvaro
    Alberto Serrano-Olvera, Juan
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (01): : 4 - 11
  • [23] Expression of Ki-67 and endoglin (CD 105) proteins in stages I and II squamous cell carcinoma of oral tongue and floor of the mouth:: association with demographic, clinical and histopathological factors -: prognostic analysis
    Matos, F.
    Brandao, L.
    Dias, F.
    Lima, R.
    Vasconcellos, S.
    Santiago, T.
    do Carmo Carvalho, M.
    ORAL ONCOLOGY, 2007, : 174 - 174
  • [24] EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology
    Monteiro, Luis Silva
    Diniz-Freitas, Marcio
    Garcia-Caballero, Tomas
    Forteza, Jeronimo
    Fraga, Maximo
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2010, 39 (07) : 571 - 578
  • [25] Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma
    King, KL
    Hwang, JJ
    Chau, GY
    Tsay, SH
    Chi, CW
    Lee, TG
    Wu, LH
    Wu, CW
    Lui, WY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (03) : 273 - 279
  • [26] Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder
    Jones, HL
    Delahunt, B
    Bethwaite, PB
    Thornton, A
    PATHOLOGY, 1997, 29 (01) : 84 - 87
  • [27] Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
    Doctor, Payal
    Arakeri, Surekha U.
    Patil, Venkatesh
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2023, 12 (02) : 35 - 47
  • [28] Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma
    Gupta, Vineet
    Ramalingam, Karthikeyan
    Yasothkumar, Dinesh
    Debnath, Diptakshi
    Sundar, Vinay
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [29] Expression of ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma
    Konstantinos, Kosmas
    Marios, Stamoulas
    Anna, Marouga
    Nikolaos, Kavantzas
    Efstratios, Patsouris
    Paulina, Athanassiadou
    DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (03) : 212 - 217
  • [30] Hepatoma upregulated protein and Ki-67 expression in resectable hepatocellular carcinoma
    Lei, Hoa-Jan
    Wang, Sheng-Yu
    Chau, Ivy Yenwen
    Li, Anna Fen-Yau
    Chau, Yat-Pang
    Hsia, Cheng-Yuan
    Chou, Shu-Cheng
    Kao, Yi-Chu
    Chau, Gar-Yang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (06) : 623 - 632